Cargando…

ATR-FTIR Spectroscopy with Chemometrics for Analysis of Saliva Samples Obtained in a Lung-Cancer-Screening Programme: Application of Swabs as a Paradigm for High Throughput in a Clinical Setting

There is an increasing need for inexpensive and rapid screening tests in point-of-care clinical oncology settings. Herein, we develop a swab “dip” test in saliva obtained from consenting patients participating in a lung-cancer-screening programme being undertaken in North West England. In a pilot st...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Francis L., Dickinson, Andrew W., Saba, Tarek, Bongers, Thomas, Singh, Maneesh N., Bury, Danielle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381591/
https://www.ncbi.nlm.nih.gov/pubmed/37511652
http://dx.doi.org/10.3390/jpm13071039
_version_ 1785080481952301056
author Martin, Francis L.
Dickinson, Andrew W.
Saba, Tarek
Bongers, Thomas
Singh, Maneesh N.
Bury, Danielle
author_facet Martin, Francis L.
Dickinson, Andrew W.
Saba, Tarek
Bongers, Thomas
Singh, Maneesh N.
Bury, Danielle
author_sort Martin, Francis L.
collection PubMed
description There is an increasing need for inexpensive and rapid screening tests in point-of-care clinical oncology settings. Herein, we develop a swab “dip” test in saliva obtained from consenting patients participating in a lung-cancer-screening programme being undertaken in North West England. In a pilot study, a total of 211 saliva samples (n = 170 benign, 41 designated cancer-positive) were randomly taken during the course of this prospective lung-cancer-screening programme. The samples (sterile Copan blue rayon swabs dipped in saliva) were analysed using attenuated total reflection Fourier-transform infrared (ATR-FTIR) spectroscopy. An exploratory analysis using principal component analysis (PCA,) with or without linear discriminant analysis (LDA), was then undertaken. Three pairwise comparisons were undertaken including: (1) benign vs. cancer following swab analysis; (2) benign vs. cancer following swab analysis with the subtraction of dry swab spectra; and (3) benign vs. cancer following swab analysis with the subtraction of wet swab spectra. Consistent and remarkably similar patterns of clustering for the benign control vs. cancer categories, irrespective of whether the swab plus saliva sample was analysed or whether there was a subtraction of wet or dry swab spectra, was observed. In each case, MANOVA demonstrated that this segregation of categories is highly significant. A k-NN (using three nearest neighbours) machine-learning algorithm also showed that the specificity (90%) and sensitivity (75%) are consistent for each pairwise comparison. In detailed analyses, the swab as a substrate did not alter the level of spectral discrimination between benign control vs. cancer saliva samples. These results demonstrate a novel swab “dip” test using saliva as a biofluid that is highly applicable to be rolled out into a larger lung-cancer-screening programme.
format Online
Article
Text
id pubmed-10381591
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103815912023-07-29 ATR-FTIR Spectroscopy with Chemometrics for Analysis of Saliva Samples Obtained in a Lung-Cancer-Screening Programme: Application of Swabs as a Paradigm for High Throughput in a Clinical Setting Martin, Francis L. Dickinson, Andrew W. Saba, Tarek Bongers, Thomas Singh, Maneesh N. Bury, Danielle J Pers Med Article There is an increasing need for inexpensive and rapid screening tests in point-of-care clinical oncology settings. Herein, we develop a swab “dip” test in saliva obtained from consenting patients participating in a lung-cancer-screening programme being undertaken in North West England. In a pilot study, a total of 211 saliva samples (n = 170 benign, 41 designated cancer-positive) were randomly taken during the course of this prospective lung-cancer-screening programme. The samples (sterile Copan blue rayon swabs dipped in saliva) were analysed using attenuated total reflection Fourier-transform infrared (ATR-FTIR) spectroscopy. An exploratory analysis using principal component analysis (PCA,) with or without linear discriminant analysis (LDA), was then undertaken. Three pairwise comparisons were undertaken including: (1) benign vs. cancer following swab analysis; (2) benign vs. cancer following swab analysis with the subtraction of dry swab spectra; and (3) benign vs. cancer following swab analysis with the subtraction of wet swab spectra. Consistent and remarkably similar patterns of clustering for the benign control vs. cancer categories, irrespective of whether the swab plus saliva sample was analysed or whether there was a subtraction of wet or dry swab spectra, was observed. In each case, MANOVA demonstrated that this segregation of categories is highly significant. A k-NN (using three nearest neighbours) machine-learning algorithm also showed that the specificity (90%) and sensitivity (75%) are consistent for each pairwise comparison. In detailed analyses, the swab as a substrate did not alter the level of spectral discrimination between benign control vs. cancer saliva samples. These results demonstrate a novel swab “dip” test using saliva as a biofluid that is highly applicable to be rolled out into a larger lung-cancer-screening programme. MDPI 2023-06-25 /pmc/articles/PMC10381591/ /pubmed/37511652 http://dx.doi.org/10.3390/jpm13071039 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Martin, Francis L.
Dickinson, Andrew W.
Saba, Tarek
Bongers, Thomas
Singh, Maneesh N.
Bury, Danielle
ATR-FTIR Spectroscopy with Chemometrics for Analysis of Saliva Samples Obtained in a Lung-Cancer-Screening Programme: Application of Swabs as a Paradigm for High Throughput in a Clinical Setting
title ATR-FTIR Spectroscopy with Chemometrics for Analysis of Saliva Samples Obtained in a Lung-Cancer-Screening Programme: Application of Swabs as a Paradigm for High Throughput in a Clinical Setting
title_full ATR-FTIR Spectroscopy with Chemometrics for Analysis of Saliva Samples Obtained in a Lung-Cancer-Screening Programme: Application of Swabs as a Paradigm for High Throughput in a Clinical Setting
title_fullStr ATR-FTIR Spectroscopy with Chemometrics for Analysis of Saliva Samples Obtained in a Lung-Cancer-Screening Programme: Application of Swabs as a Paradigm for High Throughput in a Clinical Setting
title_full_unstemmed ATR-FTIR Spectroscopy with Chemometrics for Analysis of Saliva Samples Obtained in a Lung-Cancer-Screening Programme: Application of Swabs as a Paradigm for High Throughput in a Clinical Setting
title_short ATR-FTIR Spectroscopy with Chemometrics for Analysis of Saliva Samples Obtained in a Lung-Cancer-Screening Programme: Application of Swabs as a Paradigm for High Throughput in a Clinical Setting
title_sort atr-ftir spectroscopy with chemometrics for analysis of saliva samples obtained in a lung-cancer-screening programme: application of swabs as a paradigm for high throughput in a clinical setting
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381591/
https://www.ncbi.nlm.nih.gov/pubmed/37511652
http://dx.doi.org/10.3390/jpm13071039
work_keys_str_mv AT martinfrancisl atrftirspectroscopywithchemometricsforanalysisofsalivasamplesobtainedinalungcancerscreeningprogrammeapplicationofswabsasaparadigmforhighthroughputinaclinicalsetting
AT dickinsonandreww atrftirspectroscopywithchemometricsforanalysisofsalivasamplesobtainedinalungcancerscreeningprogrammeapplicationofswabsasaparadigmforhighthroughputinaclinicalsetting
AT sabatarek atrftirspectroscopywithchemometricsforanalysisofsalivasamplesobtainedinalungcancerscreeningprogrammeapplicationofswabsasaparadigmforhighthroughputinaclinicalsetting
AT bongersthomas atrftirspectroscopywithchemometricsforanalysisofsalivasamplesobtainedinalungcancerscreeningprogrammeapplicationofswabsasaparadigmforhighthroughputinaclinicalsetting
AT singhmaneeshn atrftirspectroscopywithchemometricsforanalysisofsalivasamplesobtainedinalungcancerscreeningprogrammeapplicationofswabsasaparadigmforhighthroughputinaclinicalsetting
AT burydanielle atrftirspectroscopywithchemometricsforanalysisofsalivasamplesobtainedinalungcancerscreeningprogrammeapplicationofswabsasaparadigmforhighthroughputinaclinicalsetting